US Patent 7674291 Human skin equivalents expressing exogenous polypeptides

Patent 7674291 was granted and assigned to Stratatech Corporation on March, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 2 Mar, 2024

"update inverses"

Golden AI

edited on 2 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11911444 Use of human skin substitutes expressing exogenous IL-12 to treat a wound bed

Edits on 30 Oct, 2023

"Add patent abstract"

Golden AI

edited on 30 Oct, 2023

Edits made to:

Article (+534 characters)

Article

Patent abstract

The present invention relates generally to compositions for wound closure. More specifically, the present invention provides human skin equivalents engineered to express exogenous polypeptides (e.g., antimicrobial polypeptides and keratinocyte growth factor 2) and compositions and methods for making human skin equivalents engineered to express exogenous polypeptides. In addition, the present invention provides methods for treatment of wounds with human skin equivalents engineered to express exogenous polypeptides.

Edits on 18 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 18 Sep, 2023

Edits made to:

Infobox (+2 properties)

Infobox

Patent Inventor Names

John M. Centanni0

Lynn Allen-Hoffmann0

Edits on 24 May, 2023

"Remove website redirecting to Patent Public Search front page"